The drug "Nodgeron" instructions is as a muscle relaxant, which is a derivative of adamantane and has a central effect. Taking this medicine has a cerebrovasodilating, nootropic, psychostimulating and antihypoxic effect on the patient's body. As a result of prolonged use of the Noojeron preparation (the instruction emphasizes this) fatigue decreases, the
concentration of attention and weakened memory improves, and the symptoms of depression are completely eliminated. In addition, this medication has a positive effect on stiffness, reducing the manifestations of bradykinesia and rigidity. At the same time, the basis of the action of this drug is a decrease in the stimulating effect of glutamate neurons directly on the neostriatum and a decrease in the intake of Ca2 + in neurons.
The
nootropic drug "Noojeron" is produced, the instructions for which are enclosed by the manufacturer in each box, in the form of oval gray tablets. The composition of one tablet as the main component includes about ten milligrams of memantine hydrochloride. Additional ingredients are calcium hydrogen phosphate, magnesium stearate, microcrystalline cellulose,
silicon dioxide and croscarmellose sodium. The composition of the membrane includes substances such as hypromellose, macrogol and polydextrose. Black
iron oxide and
titanium dioxide are also contained in a small amount
.
The instruction advises patients to take the psycho-stimulating medicine Noojeron for patients suffering from Alzheimer's disease with severe or moderate dementia. However, if a patient has a severe form of liver failure, this drug is strictly contraindicated. In addition, you should not use this nootropic agent during lactation or bearing a child. People who have not reached the age of eighteen should likewise not take Noojeron tablets. In addition to all of the above, the list of contraindications includes individual intolerance to memantine hydrochloride, as well as an allergic reaction to any auxiliary substances.
With great care, doctors prescribe this psychostimulating drug for epilepsy and heart failure. People with arterial hypertension or thyrotoxicosis also need to refrain from taking the Noojeron medication. Doctors' reviews also indicate the undesirability of its use in renal failure, myocardial infarction and a history of seizures.
As for the most common side effects, the appearance of which can be triggered by the use of the Noogeron preparation, here one can distinguish conditions such as drowsiness, confusion, hallucinations, increased fatigue, and general weakness. In addition, convulsions, headaches, psychosis, gait disturbance, dizziness, thromboembolism, pancreatitis, skin rash, itching, and venous thrombosis are sometimes noted.